Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details)

v2.4.0.6
SUBSEQUENT EVENTS (Details) (USD $)
Mar. 31, 2013
Sep. 30, 2012
Mar. 31, 2012
Sep. 30, 2011
Sep. 30, 2007
Cash $ 1,765,208 $ 2,632,413 $ 775,341 $ 469,786 $ 197,275
Prepaid expenses 208,838 218,242      
Total Current Assets 1,974,046 2,850,655      
EQUIPMENT, net 38,383 43,111      
OTHER ASSETS          
Patent costs, net 584,866 623,654      
TOTAL ASSETS 2,597,295 3,517,420      
Accounts payable and accrued expenses 314,293 300,462      
Notes payable 3,643 22,037      
Total Current Liabilities 317,936 1,091,195      
TOTAL LIABILITIES 317,936 1,091,195      
Preferred stock, Series B 544 558      
Common stock 4,970 4,726      
Additional paid-in capital 33,314,851 30,963,228      
Accumulated deficit (21,628,748) (21,628,748)      
Deficit accumulated during the development stage (9,412,258) (6,901,648)      
Total Stockholders' Equity (Deficit) 2,279,359 2,426,225      
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) 2,597,295 3,517,420      
Adjustments
          
Cash 5,056,337        
OTHER ASSETS          
Common stock 424        
Additional paid-in capital 5,055,913        
Pro Forma
          
Cash 6,821,545        
Prepaid expenses 208,838        
Total Current Assets 7,030,383        
EQUIPMENT, net 38,383        
OTHER ASSETS          
Patent costs, net 584,866        
TOTAL ASSETS 7,653,632        
Accounts payable and accrued expenses 314,293        
Notes payable 3,643        
Total Current Liabilities 317,936        
TOTAL LIABILITIES 317,936        
Preferred stock, Series B 544        
Common stock 5,394        
Additional paid-in capital 38,370,764        
Accumulated deficit (21,628,748)        
Deficit accumulated during the development stage (9,412,258)        
Total Stockholders' Equity (Deficit) 7,335,696        
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 7,653,632